DAWN – Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, IncDAWN
$9.32Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $956,935,680.00
EPSttm : -1.52
Day One Biopharmaceuticals, Inc
$9.32
1.53%$0.14Float Short %
12.73
Margin Of Safety %
Put/Call OI Ratio
0.22
EPS Next Q Diff
EPS Last/This Y
0.05
EPS This/Next Y
0.32
Price
9.32
Target Price
22.25
Analyst Recom
1.22
Performance Q
35.47
Relative Volume
0.4
Beta
-1.27
Ticker: DAWN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-02 | DAWN | 8.43 | 0.18 | 2.40 | 56680 |
| 2025-12-03 | DAWN | 8.31 | 0.18 | 0.10 | 57054 |
| 2025-12-04 | DAWN | 8.34 | 0.19 | 2.49 | 57028 |
| 2025-12-05 | DAWN | 7.91 | 0.18 | 0.57 | 57001 |
| 2025-12-08 | DAWN | 8.64 | 0.19 | 2.06 | 57138 |
| 2025-12-09 | DAWN | 8.26 | 0.20 | 0.60 | 58248 |
| 2025-12-10 | DAWN | 8.51 | 0.20 | 1.28 | 58441 |
| 2025-12-11 | DAWN | 8.43 | 0.21 | 0.27 | 58561 |
| 2025-12-12 | DAWN | 8.36 | 0.21 | 0.51 | 58566 |
| 2025-12-15 | DAWN | 8.27 | 0.21 | 0.71 | 58562 |
| 2025-12-16 | DAWN | 8.27 | 0.21 | 0.03 | 58922 |
| 2025-12-17 | DAWN | 8.77 | 0.21 | 0.01 | 59968 |
| 2025-12-18 | DAWN | 9.97 | 0.20 | 0.15 | 61661 |
| 2025-12-19 | DAWN | 9.25 | 0.21 | 0.03 | 68327 |
| 2025-12-22 | DAWN | 9.57 | 0.19 | 0.06 | 47158 |
| 2025-12-23 | DAWN | 9.65 | 0.19 | 1.84 | 49771 |
| 2025-12-26 | DAWN | 9.45 | 0.21 | 6.59 | 51101 |
| 2025-12-29 | DAWN | 9.38 | 0.22 | 0.95 | 51546 |
| 2025-12-30 | DAWN | 9.18 | 0.22 | 2.07 | 51583 |
| 2025-12-31 | DAWN | 9.32 | 0.22 | 0.23 | 51608 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-02 | DAWN | 8.43 | 68.1 | - | -0.97 |
| 2025-12-03 | DAWN | 8.31 | 68.1 | - | -0.97 |
| 2025-12-04 | DAWN | 8.34 | 68.1 | - | -0.97 |
| 2025-12-05 | DAWN | 7.92 | 68.1 | - | -0.97 |
| 2025-12-08 | DAWN | 8.64 | 68.1 | - | -0.97 |
| 2025-12-09 | DAWN | 8.25 | 68.1 | - | -0.97 |
| 2025-12-10 | DAWN | 8.51 | 68.1 | - | -0.97 |
| 2025-12-11 | DAWN | 8.43 | 68.1 | - | -0.97 |
| 2025-12-12 | DAWN | 8.37 | 68.1 | - | -0.97 |
| 2025-12-15 | DAWN | 8.27 | 68.1 | - | -0.97 |
| 2025-12-16 | DAWN | 8.27 | 68.1 | - | -0.97 |
| 2025-12-17 | DAWN | 8.77 | 68.1 | - | -0.97 |
| 2025-12-18 | DAWN | 9.97 | 68.1 | - | -0.97 |
| 2025-12-19 | DAWN | 9.25 | 68.1 | - | -0.97 |
| 2025-12-22 | DAWN | 9.61 | 68.1 | - | -0.97 |
| 2025-12-23 | DAWN | 9.65 | 68.1 | - | -0.97 |
| 2025-12-26 | DAWN | 9.44 | 68.1 | - | -0.97 |
| 2025-12-29 | DAWN | 9.38 | 68.1 | - | -0.97 |
| 2025-12-30 | DAWN | 9.18 | 68.1 | - | -0.97 |
| 2025-12-31 | DAWN | 9.32 | 68.1 | - | -0.97 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-02 | DAWN | -0.19 | -0.58 | 12.20 |
| 2025-12-03 | DAWN | -0.19 | -0.58 | 12.20 |
| 2025-12-04 | DAWN | -0.19 | -0.58 | 12.20 |
| 2025-12-05 | DAWN | -0.19 | -0.58 | 12.19 |
| 2025-12-08 | DAWN | -0.19 | -0.58 | 12.19 |
| 2025-12-09 | DAWN | -0.19 | -0.58 | 12.19 |
| 2025-12-10 | DAWN | -0.19 | -0.58 | 12.91 |
| 2025-12-11 | DAWN | -0.19 | -0.58 | 12.91 |
| 2025-12-12 | DAWN | -0.19 | -0.58 | 12.91 |
| 2025-12-15 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-16 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-17 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-18 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-19 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-22 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-23 | DAWN | -0.19 | -0.89 | 12.89 |
| 2025-12-26 | DAWN | -0.19 | -0.89 | 12.73 |
| 2025-12-29 | DAWN | -0.19 | -0.89 | 12.73 |
| 2025-12-30 | DAWN | -0.19 | -0.89 | 12.73 |
| 2025-12-31 | DAWN | -0.19 | -0.89 | 12.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.2
Avg. EPS Est. Next Quarter
-0.19
Insider Transactions
-0.19
Institutional Transactions
-0.89
Beta
-1.27
Average Sales Estimate Current Quarter
44
Average Sales Estimate Next Quarter
50
Fair Value
Quality Score
38
Growth Score
28
Sentiment Score
20
Actual DrawDown %
67.5
Max Drawdown 5-Year %
Target Price
22.25
P/E
Forward P/E
PEG
P/S
7.16
P/B
2.12
P/Free Cash Flow
EPS
-1.49
Average EPS Est. Cur. Y
-0.97
EPS Next Y. (Est.)
-0.65
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-113.53
Relative Volume
0.4
Return on Equity vs Sector %
-60.9
Return on Equity vs Industry %
-45.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.21
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 184
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading